Tartaglione, I. Origa, R. Kattamis, A. Pfeilstöcker, M. Gunes, S. Crowe, S. Fagan, N. Vincenzi, B. Ruffo, G.B., Two-year long safety and efficacy of deferasirox film-coated tablets in patients with thalassemia or lower/intermediate risk MDS: Phase 3 results from a subset of patients previously treated with deferasirox in the ECLIPSE study, Experimental Hematology and Oncology, (9), 2020, BioMed Central Ltd.,